Health
Internal AstraZeneca safety report sheds light on neurological condition suffered by vaccine trial participant – CTV News
An internal safety report by pharmaceutical giant AstraZeneca describes how a participant in its vaccine trial developed trouble walking, weakness and pain in her arms, and other symptoms.
CNN has obtained an internal safety report by pharmaceutical giant AstraZeneca that sheds light on the neurological condition suffered by one of the participants in its coronavirus vaccine clinical trial.
The report details how the study volunteer, a previously healthy 37-year-old woman, “experienced confirmed transverse myelitis” after receiving her second dose of the vaccine, and was hospitalized on September 5.
Four days later, AstraZeneca dismissed media reports about the participant havin…
-
Noosa News10 hours agoMotorbike rider dies after car collision at Kidaman Creek, west of Sunshine Coast
-
Business22 hours agoWhat I’d buy before the ASX rebounds: 3 high-conviction share picks
-
Noosa News20 hours agoMan shot in the leg during attempted break-in at Beenleigh, Queensland
-
General11 hours agoDemocratic senators want an investigation into potential market manipulation from Trump’s inner circle